ALT - Altimmune, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts1110
Avg. Estimate-3.6-2.8-21.870
Low Estimate-3.6-2.8-21.870
High Estimate-3.6-2.8-21.870
Year Ago EPS-61.5-17.4-120.3-21.87
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate2.52M3.52M11.15M4.8M
Low Estimate2.52M3.52M11.15M4.8M
High Estimate2.52M3.52M11.15M4.8M
Year Ago Sales4.59M2.81M10.74M11.15M
Sales Growth (year/est)-45.10%25.30%3.80%-57.00%
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.-8.4-15-15-4.5
EPS Actual-61.5-17.4-7.5-4.8
Difference-53.1-2.47.5-0.3
Surprise %-632.10%-16.00%50.00%-6.70%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate-3.6-2.8-21.870
7 Days Ago-3.6-2.8-21.87-2.06
30 Days Ago-5.4-4.5-21.6-2.06
60 Days Ago-0.18-0.15-0.72-2.06
90 Days Ago-0.18-0.15-0.72-2.06
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days11N/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesALTIndustrySectorS&P 500
Current Qtr.94.10%N/AN/A0.48
Next Qtr.83.90%N/AN/A0.40
Current Year81.80%N/AN/A0.21
Next YearN/AN/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A